BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35074016)

  • 1. Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.
    Rock KS; Huang CI; Crump RE; Bessell PR; Brown PE; Tirados I; Solano P; Antillon M; Picado A; Mbainda S; Darnas J; Crowley EH; Torr SJ; Peka M
    Infect Dis Poverty; 2022 Jan; 11(1):11. PubMed ID: 35074016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad).
    Mahamat MH; Peka M; Rayaisse JB; Rock KS; Toko MA; Darnas J; Brahim GM; Alkatib AB; Yoni W; Tirados I; Courtin F; Brand SPC; Nersy C; Alfaroukh IO; Torr SJ; Lehane MJ; Solano P
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005792. PubMed ID: 28750007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
    Antillon M; Huang CI; Sutherland SA; Crump RE; Bessell PR; Shaw APM; Tirados I; Picado A; Biéler S; Brown PE; Solano P; Mbainda S; Darnas J; Wang-Steverding X; Crowley EH; Peka M; Tediosi F; Rock KS
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011396. PubMed ID: 37498938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of tsetse control using 'Tiny Targets' in the sleeping sickness endemic forest area of Bonon in Côte d'Ivoire: Implications for comparing costs across different settings.
    Courtin F; Kaba D; Rayaisse JB; Solano P; Torr SJ; Shaw APM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010033. PubMed ID: 34986176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vector competence of sterile male Glossina fuscipes fuscipes for Trypanosoma brucei brucei: implications for the implementation of the sterile insect technique in a sleeping sickness focus in Chad.
    Mahamat MH; Ségard A; Rayaisse JB; Argiles-Herrero R; Parker AG; Solano P; Abd-Alla AMM; Bouyer J; Ravel S
    Parasit Vectors; 2023 Mar; 16(1):111. PubMed ID: 36949538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering 'tiny targets' in a remote region of southern Chad: a cost analysis of tsetse control in the Mandoul sleeping sickness focus.
    Rayaisse JB; Courtin F; Mahamat MH; Chérif M; Yoni W; Gadjibet NMO; Peka M; Solano P; Torr SJ; Shaw APM
    Parasit Vectors; 2020 Aug; 13(1):419. PubMed ID: 32795375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC.
    Huang CI; Crump RE; Crowley EH; Hope A; Bessell PR; Shampa C; Mwamba Miaka E; Rock KS
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011299. PubMed ID: 37115809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of trypanosomes in humans and cattle in the HAT foci Mandoul and Maro, Southern Chad-A matter of concern for zoonotic potential?
    Ibrahim MAM; Weber JS; Ngomtcho SCH; Signaboubo D; Berger P; Hassane HM; Kelm S
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009323. PubMed ID: 34106914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data.
    Davis CN; Castaño MS; Aliee M; Patel S; Miaka EM; Keeling MJ; Spencer SEF; Chitnis N; Rock KS
    Clin Infect Dis; 2021 Jun; 72(Suppl 3):S146-S151. PubMed ID: 33905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.
    Wamboga C; Matovu E; Bessell PR; Picado A; Biéler S; Ndung'u JM
    PLoS One; 2017; 12(10):e0186429. PubMed ID: 29023573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo.
    Aliee M; Castaño S; Davis CN; Patel S; Miaka EM; Spencer SEF; Keeling MJ; Chitnis N; Rock KS
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):245-252. PubMed ID: 33611586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Mandoul human African trypanosomiasis focus in Chad: from evaluation to control].
    Louis FJ; Djimadoum NA; Kohagne TL; Simarro PP
    Med Trop (Mars); 2009 Feb; 69(1):7-12. PubMed ID: 19499723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.
    Crump RE; Huang CI; Spencer SEF; Brown PE; Shampa C; Mwamba Miaka E; Rock KS
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010599. PubMed ID: 35816487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?
    Selby R; Wamboga C; Erphas O; Mugenyi A; Jamonneau V; Waiswa C; Torr SJ; Lehane M
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007550. PubMed ID: 31412035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo.
    Davis CN; Rock KS; Antillón M; Miaka EM; Keeling MJ
    BMC Med; 2021 Apr; 19(1):86. PubMed ID: 33794881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.
    Antillon M; Huang CI; Crump RE; Brown PE; Snijders R; Miaka EM; Keeling MJ; Rock KS; Tediosi F
    Nat Commun; 2022 Feb; 13(1):1051. PubMed ID: 35217656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness.
    Castaño MS; Aliee M; Mwamba Miaka E; Keeling MJ; Chitnis N; Rock KS
    J Infect Dis; 2020 Jun; 221(Suppl 5):S539-S545. PubMed ID: 31876949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
    Geerts M; Van Reet N; Leyten S; Berghmans R; Rock KS; Coetzer THT; Eyssen LE; Büscher P
    Clin Infect Dis; 2021 Nov; 73(9):e2477-e2483. PubMed ID: 32856049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of vector control to protect people from sleeping sickness in the focus of Bonon (Côte d'Ivoire).
    Kaba D; Djohan V; Berté D; Ta BTD; Selby R; Kouadio KAM; Coulibaly B; Traoré G; Rayaisse JB; Fauret P; Jamonneau V; Lingue K; Solano P; Torr SJ; Courtin F
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009404. PubMed ID: 34181651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South-West Burkina Faso.
    Compaoré CFA; Kaboré J; Ilboudo H; Thomas LF; Falzon LC; Bamba M; Sakande H; Koné M; Kaba D; Bougouma C; Adama I; Amathe O; Belem AMG; Fèvre EM; Büscher P; Lejon V; Jamonneau V
    Parasite; 2022; 29():25. PubMed ID: 35543528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.